quantisnow
FeedTopReportsPricing
⌘K
Live feed
12:31:40·736d
NEWSRelease
Adial Pharmaceuticals Inc logo
Dare Bioscience Inc. logo
Finch Therapeutics Group Inc. logo
+9

12 Health Care Stocks Moving In Wednesday's Intraday Session

ADIL· Adial Pharmaceuticals IncDARE· Dare Bioscience Inc.FNCH· Finch Therapeutics Group Inc.GRTX· Galera Therapeutics Inc.INVO· INVO BioScience Inc.LGVN· Longeveron Inc.
Health Care
Original source

Companies

  • ADIL
    Adial Pharmaceuticals Inc
    Health Care
  • DARE
    Dare Bioscience Inc.
    Health Care
  • FNCH
    Finch Therapeutics Group Inc.
    Health Care
  • GRTX
    Galera Therapeutics Inc.
    Health Care
  • INVO
    INVO BioScience Inc.
    Health Care
  • LGVN
    Longeveron Inc.
    Health Care
  • RANI
    Rani Therapeutics Holdings Inc.
    Health Care
  • SAGE
    Sage Therapeutics Inc.
    Health Care
  • SINT
    SiNtx Technologies Inc.
    Health Care
  • SXTC
    China SXT Pharmaceuticals Inc.
    Health Care
  • VIRX
    Viracta Therapeutics Inc.
    Health Care
  • VNDA
    Vanda Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Apr 14RANIUpdateLake Street$9.00
  • Apr 13SINTUpdateH.C. Wainwright$10.00
  • Mar 5VNDAUpdateTruist$18.00
  • Nov 5VNDAUpdateB. Riley Securities$11.00
  • Mar 11SAGEUpdateBofA Securities$5.00
  • Dec 6LGVNUpdateROTH MKM$10.00

Related

  • SEC18h
    SEC Form DEFA14A filed by Vanda Pharmaceuticals Inc.
  • SEC18h
    SEC Form DEF 14A filed by Vanda Pharmaceuticals Inc.
  • PR1d
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • SEC1d
    Vanda Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR1d
    Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors
  • PR2d
    Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
  • SEC2d
    SEC Form 425 filed by Galera Therapeutics Inc.
  • SEC2d
    SEC Form 425 filed by Galera Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022